- Conditions
- Generalized Anxiety Disorder, Anxiety
- Interventions
- Odorant Cue
- Behavioral
- Lead sponsor
- Emory University
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2005
- U.S. locations
- 1
- States / cities
- Atlanta, Georgia
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 217–239
of 239
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Generalized Anxiety Disorder
- Interventions
- massage, thermotherapy, relaxing environment
- Behavioral
- Lead sponsor
- Kaiser Permanente
- Other
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 68 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 1
- States / cities
- Seattle, Washington
- Conditions
- Bipolar Disorder, Panic Disorder, Generalized Anxiety Disorder
- Interventions
- Ziprasidone, Placebo
- Drug
- Lead sponsor
- VA Palo Alto Health Care System
- Federal
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 49 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010 – 2011
- U.S. locations
- 3
- States / cities
- Palo Alto, California • Tampa, Florida • Mason, Ohio
- Conditions
- Generalized Anxiety Disorder
- Interventions
- PD-0332334
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 65 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009
- U.S. locations
- 2
- States / cities
- Orlando, Florida • Prairie Village, Kansas
- Conditions
- Generalized Anxiety Disorder
- Interventions
- eszopiclone, Placebo
- Drug
- Lead sponsor
- Sumitomo Pharma America, Inc.
- Industry
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 456 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008
- U.S. locations
- 57
- States / cities
- Birmingham, Alabama • Arcadia, California • Beverly Hills, California + 51 more
- Conditions
- Parkinson's Disease
- Interventions
- Surgical infusion of AAV-GAD into the subthalamic nucleus
- Genetic
- Lead sponsor
- Neurologix, Inc.
- Industry
- Eligibility
- 25 Years to 75 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2005
- U.S. locations
- 1
- States / cities
- Manhasset, New York
- Conditions
- Generalized Anxiety Disorder
- Interventions
- CBT, Usual Care
- Behavioral · Other
- Lead sponsor
- Baylor College of Medicine
- Other
- Eligibility
- 60 Years and older
- Enrollment
- 222 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2015
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Generalized Anxiety Disorder
- Interventions
- Not listed
- Lead sponsor
- Hartford Hospital
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 55 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012 – 2014
- U.S. locations
- 1
- States / cities
- Hartford, Connecticut
- Conditions
- Generalized Anxiety Disorder
- Interventions
- Placebo, DT120
- Other · Drug
- Lead sponsor
- Definium Therapeutics US, Inc.
- Industry
- Eligibility
- 18 Years to 74 Years
- Enrollment
- 245 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 13
- States / cities
- Little Rock, Arkansas • Los Angeles, California • Bradenton, Florida + 9 more
- Conditions
- Generalized Anxiety Disorder
- Interventions
- ITI-1284 10 mg, ITI-1284 20 mg, Placebo
- Drug
- Lead sponsor
- Intra-Cellular Therapies, Inc.
- Industry
- Eligibility
- Not listed
- Enrollment
- 705 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 25
- States / cities
- Glendale, California • Imperial, California • Lemon Grove, California + 17 more
- Conditions
- Generalized Anxiety Disorder
- Interventions
- Gabitril
- Drug
- Lead sponsor
- Cephalon
- Industry
- Eligibility
- 18 Years to 64 Years
- Enrollment
- 440 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2006
- U.S. locations
- 21
- States / cities
- Birmingham, Alabama • Beverly Hills, California • Northridge, California + 17 more
- Conditions
- Generalized Anxiety Disorder
- Interventions
- AMP, Applied Relaxation (AR), Clinical Monitoring (CM), Combining the AMP and AR
- Behavioral
- Lead sponsor
- San Diego State University
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 193 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2016
- U.S. locations
- 1
- States / cities
- San Diego, California
- Conditions
- Anxiety Disorders, Mental Health
- Interventions
- Hypericum perforatum (St. John's wort)
- Drug
- Lead sponsor
- National Center for Complementary and Integrative Health (NCCIH)
- NIH
- Eligibility
- 18 Years and older
- Enrollment
- 56 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2006
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
- Conditions
- Rheumatoid Arthritis
- Interventions
- Indocyanine Green, MultiSpectral Imaging System
- Drug · Device
- Lead sponsor
- University of Rochester
- Other
- Eligibility
- 18 Years to 89 Years
- Enrollment
- 2 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2020
- U.S. locations
- 1
- States / cities
- Rochester, New York
- Conditions
- Generalized Anxiety Disorder
- Interventions
- Cognitive Behavior Therapy, Telephone check-in
- Behavioral
- Lead sponsor
- Baylor College of Medicine
- Other
- Eligibility
- 60 Years and older
- Enrollment
- 148 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2015
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Anxiety Disorders
- Interventions
- Duloxetine Hydrochloride, placebo
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 380 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2007
- U.S. locations
- 19
- States / cities
- Sherman Oaks, California • Fort Myers, Florida • Atlanta, Georgia + 16 more
- Conditions
- Epilepsy, Anxiety
- Interventions
- Pregabalin-Lyrica, Sertraline
- Drug
- Lead sponsor
- Rush University Medical Center
- Other
- Eligibility
- 18 Years to 80 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2012
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Generalized Anxiety Disorder
- Interventions
- Vortioxetine, Placebo
- Drug
- Lead sponsor
- Takeda
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 457 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 40
- States / cities
- Birmingham, Alabama • Anaheim, California • Cerritos, California + 37 more
- Conditions
- Generalized Anxiety Disorder (GAD), Anxiety Disorders
- Interventions
- Low-Dose Cannabidiol, Placebo Matched to Moderate-Dose Cannabidiol, Moderate-Dose Cannabidiol, Placebo Matched to Low-Dose Cannabidiol
- Drug
- Lead sponsor
- Wayne State University
- Other
- Eligibility
- 18 Years to 45 Years
- Enrollment
- 90 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Detroit, Michigan
- Conditions
- Generalized Anxiety Disorder
- Interventions
- ITI-1284 10 mg, ITI-1284 20 mg, Placebo
- Drug
- Lead sponsor
- Intra-Cellular Therapies, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 570 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2028
- U.S. locations
- 25
- States / cities
- Birmingham, Alabama • Little Rock, Arkansas • Rogers, Arkansas + 21 more
- Conditions
- Chronic Pain, Generalized Anxiety Disorder
- Interventions
- Low Intensity Focused Ultrasound
- Device
- Lead sponsor
- Virginia Polytechnic Institute and State University
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Roanoke, Virginia
- Conditions
- Social Phobia, Generalized Anxiety Disorder, Separation Anxiety Disorder
- Interventions
- Sertraline
- Drug
- Lead sponsor
- University of Michigan
- Other
- Eligibility
- 7 Years to 19 Years
- Enrollment
- 156 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010 – 2015
- U.S. locations
- 1
- States / cities
- Ann Arbor, Michigan
- Conditions
- Anorexia Nervosa, Major Depressive Disorder, Generalized Anxiety Disorder, Panic Disorder, Brain Injury
- Interventions
- Isoproterenol, Normal saline
- Drug
- Lead sponsor
- Laureate Institute for Brain Research, Inc.
- Other
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 97 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2023
- U.S. locations
- 1
- States / cities
- Tulsa, Oklahoma